Bone cell study explores direct effects of rickets drug

This study looks at bone cells from children having surgery for craniosynostosis (early skull bone fusion). Researchers want to see how burosumab and vitamin D directly affect these cells, especially in children with a rare bone disease called hypophosphatemic rickets. The goal is to learn more about how these treatments work on bone, not to test a new therapy.